We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
First published during the 2022 to 2024 Sunak Conservative government
Advice on names and presentation of nicotine-containing electronic cigarettes and refill containers on packaging.
Research exploring data from teacher assessments about pupil progress in reading, writing and maths, and its contributing factors.
First published during the 2019 to 2022 Johnson Conservative government
Almost £20 million from the Levelling Up Fund will be invested in the Bournemouth seafront.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
The scheme enables eligible households to purchase a leasehold interest (‘share’) in their current social home on similar terms and at a similar cost to if they had purchased their Grenfell home through the statutory Right to Buy scheme.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).